NCT05064930View on ClinicalTrials.gov

The Efficacy of Single-strain Probiotics in Patients With Irritable Bowel Syndrome

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

July 31, 2022

Conditions
Irritable Bowel Syndrome
Interventions
DIETARY_SUPPLEMENT

Probiotic Bifidobacterium lactis

The probiotic will be administered orally over a period of 12 weeks.

DIETARY_SUPPLEMENT

Probiotic Bacillus coagulans

The probiotic will be administered orally over a period of 12 weeks.

DIETARY_SUPPLEMENT

Placebo

Maltodextrin as a placebo will be administered orally over a period of 12 weeks. The taste and appearance of the placebo will be similar to those of the probiotic formulation.

Trial Locations (1)

Unknown

Medical University of Lublin, Lublin

All Listed Sponsors
collaborator

Medical University of Lublin

OTHER

lead

Nordic Biotic Sp. z o.o.

INDUSTRY

NCT05064930 - The Efficacy of Single-strain Probiotics in Patients With Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter